Evidence map›Paper›PMID 42427418›Full record

ArticleAdvanced biomedical research2026

Anti-

Bahram Rostami, Hamid Hasanpour, Sanaz Jafarpour Azami, Mona Roozbehani, Saeideh Hashemi-Hafshejani, Omid Raiesi, Muhammad I Getso, Alireza Badirzadeh, Shahab Falahi, Reza Pakzad and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced biomedical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Bahram RostamiDepartment of Parasitology and Mycology, School of Allied Medical Sciences, Ilam University of Medical Sciences, Ilam, Iran.
Hamid HasanpourDepartment of Parasitology and Mycology, School of Allied Medical Sciences, Ilam University of Medical Sciences, Ilam, Iran.
Sanaz Jafarpour AzamiDepartment of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mona RoozbehaniVaccine Research Center, Iran University of Medical Sciences, Tehran, Iran.
Saeideh Hashemi-HafshejaniDepartment of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Omid RaiesiDepartment of Parasitology and Mycology, School of Allied Medical Sciences, Ilam University of Medical Sciences, Ilam, Iran.
Muhammad I GetsoDepartment of Medical Microbiology and Parasitology, Faculty of Clinical Sciences, College of Health Sciences, Bayero University Kano, PMB 3011, Kano, Nigeria.
Alireza BadirzadehDepartment of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Shahab FalahiZoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Reza PakzadDepartment of Epidemiology, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran.
Mohammad Davoodzadeh GholamiDepartment of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Hesam YousefiDepartment of Pharmaceutical Care, Sajad Hospital, Kermanshah, Iran.
Razi NaserifarDepartment of Parasitology and Mycology, School of Allied Medical Sciences, Ilam University of Medical Sciences, Ilam, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study evaluates Materials and Methods: CuNPs were green synthesized using the aqueous extract of Results: CuNPs had a particle size of less than 20 nm, with a maximum peak at 315 nm, according to transmission electron microscopy. The highest mortality rate was observed at 160 ppm concentration, and after 8 h of exposure, it was demonstrated by the result of flow cytometry. Furthermore, oral administration of CuNPs increased oral bioavailability and mice survival time and reduced parasitemia. Green synthesized CuNPs by Conclusions: To achieve effective treatment against toxoplasmosis, it is suggested that more studies will be done on other strains, especially type II. Finally, it seems that the use of CuNPs can be helpful as a supplementary treatment alongside common treatments.

Indexed as

Antiparasiticcopper nanoparticlesgreen synthesisnanomedicinetoxoplasmosis

Identifiers

PMID42427418
PMCPMC13349355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.